MonaLisa PN 30.
One active ingredient. Undiluted. 30 mg/mL of long-chain salmon polynucleotide — the topical skin-needling serum that Seoul made famous, now in Australian clinics.
Designed as a topical companion to skin needling. One active. Published concentration. Manufactured by GENOSS in Seoul, South Korea.
Listed on the Australian Register of Therapeutic Goods.
Direct supply from manufacturer to your clinic.
Local training, mentorship and same-day response.
Most boosters on the Australian market are fragmented — blended with six to eight other actives, concentration undisclosed.
MonaLisa PN 30 takes the opposite approach. One active. Long-chain polynucleotide. Published concentration. The kind of product you can describe in a single sentence to a patient — paired with skin-needling for visible, defensible quality outcomes.
The serum
Korea raves about.
Long before PN became a category in Australia, it was the standard topical adjunct in Seoul's most respected aesthetic clinics — the active that sat behind the glass-skin and needling protocols Korean patients fly in for.
MonaLisa PN 30 is that same single-active formulation, manufactured by GENOSS in South Korea, supplied directly to Australian clinics by Power to Practice.
“The serum behind Korea's signature glass-skin protocol.”
“We pair it with every skin-needling session — patients ask for it by name.”
“Single active, published concentration. We finally have something honest to put on the menu.”
A product you can explain in one sentence.
Long-chain, not fragmented
PN 30 is intact polynucleotide — the premium form. Not the broken-down PDRN found in many topical boosters on the market.
30 mg/mL — published
We disclose the active concentration on every batch. Most competitor blends keep their concentration confidential.
Built for the needle
Designed as a topical companion to in-clinic skin needling — paired with microneedling, your operators get a clean, single-active serum that drives visible quality outcomes.
Made in Seoul
Manufactured by GENOSS in South Korea — the home of the K-skin protocols that built the PN category. The serum Korean clinics already trust.
Polynucleotide concentration
Full INCI Profile
| Ingredient | Conc. | Function |
|---|---|---|
| Aqua (Water) | 95.97% | Solvent |
| Sodium DNAActive | 3.00% | Skin-conditioning |
| Sodium Chloride | 0.66% | Isotonic agent |
| Disodium Phosphate | 0.27% | Buffer |
| Sodium Phosphate | 0.10% | Buffer |
Product Specifications
- Product
- MonaLisa PN 30
- Active
- Sodium DNA (Polynucleotide)
- Concentration
- 30 mg/mL
- Source
- Salmon DNA · purified long-chain PN
- Volume
- 2.0 mL per unit
- Application
- Topical · skin-needling adjunct
- Storage
- 2–25 °C, away from sunlight
- Shelf Life
- 3 years from manufacture
- Manufacturer
- GENOSS Co., Ltd. — Seoul, South Korea
- Pack
- 2.0 mL × 1 syringe